Across TCGA pan-cancer cohorts, LINC02741 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC02741’s most consistent transcriptional readouts.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC02741 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02741 is over-expressed in tumor.
LIHC are the cancer types where LINC02741 tumor–normal differential expression is most reproducible.